Allergy Therapeutics plc (LON:AGY – Get Free Report) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 8.24 ($0.11) and traded as high as GBX 8.50 ($0.11). Allergy Therapeutics shares last traded at GBX 8.26 ($0.11), with a volume of 1,752,106 shares changing hands.
Allergy Therapeutics Stock Up 0.7%
The stock’s 50-day moving average is GBX 8.24 and its 200-day moving average is GBX 7.65. The stock has a market cap of £393.71 million, a P/E ratio of -11.47, a price-to-earnings-growth ratio of -30.70 and a beta of 1.40. The company has a current ratio of 1.63, a quick ratio of 1.48 and a debt-to-equity ratio of 835.48.
Allergy Therapeutics Company Profile
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Featured Stories
- Five stocks we like better than Allergy Therapeutics
- About the Markup Calculator
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- What is a penny stock? A comprehensive guide
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- A Deeper Look at Bid-Ask Spreads
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
